Webinar Header

TAMEST Conversation on COVID-19: Treatment and Vaccine Development

TAMEST (The Academy of Medicine, Engineering and Science of Texas) hosted a conversation on the development of treatments and vaccines for COVID-19 on Thursday, June 11, 2020. TAMEST members, Texas’ greater research community and more heard directly from scientists at the frontier of treatment and vaccine development to learn about their research on therapies and the overall path to and possible timetables for vaccine development.

Ellen Gritz

Moderator: Florence P. Haseltine, M.D., Ph.D. (NAM)
Presidential Distinguished Professor
The University of Texas at Arlington

Ellen Gritz

Speaker: Maria Elena Bottazzi, Ph.D.
Associate Dean
National School of Tropical Medicine
Baylor College of Medicine

Speaker: Mamta K. Jain, M.D.
Professor
Internal Medicine
UT Southwestern Medical Center

Speaker: Scott C. Weaver, Ph.D.
John Sealy Distinguished Chair in Human Infections and Immunity
The University of Texas Medical Branch

About TAMEST

TAMEST was co-founded in 2004 by the Honorable Kay Bailey Hutchison and Nobel Laureates Michael S. Brown, M.D., and Richard E. Smalley, Ph.D. With more than 300 members and 18 member institutions, TAMEST is composed of the Texas-based members of the three National Academies (National Academy of Medicine, National Academy of Engineering, and National Academy of Sciences), the Royal Society and the state’s 11 Nobel Laureates. We bring together the state’s brightest minds in medicine, engineering, science and technology to foster collaboration, and to advance research, innovation and business in Texas. TAMEST’s unique interdisciplinary model has become an effective recruitment tool for top research and development centers across Texas. Since our founding, more than 225 TAMEST members have been inducted into the National Academies or relocated to Texas.

 

TAMEST The Academy of Medicine, Engineering & Science of Texas